1. Beldon P. Abnormal scar formation in wound healing. Nurs Times. 2000; 96:44–45.
2. Clark JA, Cheng JC, Leung KS. Mechanical properties of normal skin and hypertrophic scars. Burns. 1996; 22:443–446.
Article
3. Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. Hypertrophic burn scars: analysis of variables. J Trauma. 1983; 23:895–898.
4. Baryza MJ, Baryza GA. The Vancouver scar scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995; 16:535–538.
Article
5. Kim SB, Lee IO, Kong MH, Lee MK, Kim NS, Choi YS, et al. Postoperative pain evaluation: facial rating scale compared with visual analogue scale. Korean J Anesthesiol. 2000; 39:696–699.
Article
6. Latarjet J, Choinère M. Pain in burn patients. Burns. 1995; 21:344–348.
Article
7. Urioste SS, Arndt KA, Dover JS. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg. 1999; 18:159–171.
Article
8. Alster TS, West TB. Treatment of scars: a review. Ann Plast Surg. 1997; 39:418–432.
Article
9. Hawkins HK. Pathophysiology of the burn scar. In : Herndon DN, editor. Total burn care. 3rd ed. Philadelphia: Saunders Elsevier;2007. p. 608–619.
10. Nedelec B, Shankowsky HA, Tredget EE. Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil. 2000; 21:205–212.
11. Van den Kerckhove E, Stappaerts K, Boeckx W, Van den Hof B, Monstrey S, Van der Kelen A, et al. Silicones in the rehabilitation of burns: a review and overview. Burns. 2001; 27:205–214.
Article
12. Mustoe TA. Scars and keloids. BMJ. 2004; 328:1329–1330.
Article
13. Van Loey NE, Bremer M, Faber AW, Middelkoop E, Nieuwenhuis MK. Itching following burns: epidemiology and predictors. Br J Dermatol. 2008; 158:95–100.
Article
14. Forbes-Duchart L, Cooper J, Nedelec B, Ross L, Quanbury A. Burn therapists' opinion on the application and essential characteristics of a burn scar outcome measure. J Burn Care Res. 2009; 30:792–800.
Article
15. Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther. 2008; 21:32–41.
Article
16. Savin J. How should we define itching. J AM Acad Dermatol. 1998; 39:268–269.
Article
17. Reich A, Szepietowski JC. Opioid-induced pruritus: an update. Clin Exp Dermatol. 2010; 35:2–6.
Article
18. Schmelz M. How pain becomes itch. Pain. 2009; 144:14–15.
Article
19. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006; 7:535–547.
Article
20. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science. 2009; 325:1531–1534.
Article
21. Ward L, Wright E, McMahon SB. A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain. Pain. 1996; 64:129–138.
Article
22. Bigliardi-Qi M, Lipp B, Sumanovski LT, Buechner SA, Bigliardi PL. Changes of epidermal mu-opiate receptor expression and nerve endings in chronic atopic dermatitis. Dermatology. 2005; 210:91–99.
Article
23. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007; 127:514–525.
Article
24. Moyer KE, Saggers GC, Ehrlich HP. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair Regen. 2004; 12:269–275.
Article
25. Smith CJ, Smith JC, Finn MC. The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J Burn Care Rehabil. 1987; 8:126–131.
Article
26. Noli C, Miolo A. The mast cell in wound healing. Vet Dermatol. 2001; 12:303–313.
Article
27. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997; 77:701–730.